news

Quick Business update from the Team at SOS Cannabis

Quick Business update from the Team at SOS Cannabis

We have not posted anything for a while on our website. There is a reason for that! Despite the current COVID crisis that affected the world, medical cannabis users still needed their dosage on a regular basis. As being fully operational and 100% set for “work-at-home”, the whole team has been working around the clock to help patients getting their medical cannabis reimbursed by public insurance agencies.

The SOS Cannabis Team will be at EXPO Cannabis Montreal

The SOS Cannabis Team will be at EXPO Cannabis Montreal

Join like-minded industry professionals working in all aspects of the Cannabis Industry, including Licensed Producers, growers, investors, suppliers, healthcare providers, job-seekers and media at this premier event showcasing the best products, services and world-class speakers the industry has to offer.

RYAH Signs Partnership Agreement With SOS Cannabis for Reimbursement for Canadian Patients

RYAH Signs Partnership Agreement With SOS Cannabis for Reimbursement for Canadian Patients

NEW YORK, July 29, 2019 (GLOBE NEWSWIRE) -- RYAH Medtech Inc. (“RYAH” or the “Company”), announced today it has executed a partnership agreement with SOS cannabis (“SOS Cannabis”). The agreement will provide Canadian patients with the ability to obtain free legal representation to seek reimbursement from different government agencies for the medical costs associated with purchasing the RYAH dose-measuring vaporizer and proprietary dry-herb cartridges.

Relevium signs exclusive agreement with SOS Cannabis for reimbursement for Pediatric Patients

Relevium signs exclusive agreement with SOS Cannabis for reimbursement for Pediatric Patients

July 10, 2019 - MONTREAL, QUEBEC – Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB: “RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), announced today it has executed an exclusivity agreement to partner with SOS Cannabis to provide pediatric customers the ability to obtain free legal representation to seek reimbursement for the costs of medical cannabinoid therapy from different government agencies for the treatment of medical conditions for Pediatric Patients